Document is current
Any future updates will be listed below
-
Authors
Nagao, Chioko
Okuda, Hiroko
Bekker, Gert-Jan
Noguchi, Atsuko
Takahashi, Tsutomu
Koizumi, Akio
Youssefian, Shohab
Tezuka, Tohru
Akioka, Shinji
-
Funding
Funding for this research was provided by:
MHLW Research on the Rare and Intractable diseases Program (JPMH19FC1003, JPMH19FC1003, JPMH19FC1003, JPMH22FC1006, JPMH19FC1003)
Grand-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JP20H03229)
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 14 July 2024
First Online: 25 July 2024
Declarations
:
: The authors declare the following conflict of interests: HO, AK, and TTe report personal fees from AlphaNavi Pharma during the study period. AN, TTa, and AK have a patent pending regarding SCN11A (name of patent, ‘Pain gene and its applications’; Japanese Patent Application No. P2016-098215A). Rest all authors have no conflicting interest to disclose.
: The study design was approved by the Ethics Review Board of Kyoto University (Approval No. G0501, Approval date Aug. 2nd, 2012).
: Written informed consent for participation in this study was obtained from all participants. For children, written informed consent was obtained from their parents.
: Written informed consent for the publication of genetic and clinical data was obtained from all participants. The parents of the children signed written informed consent for the publication of genetic and clinical data.
